A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort-Reference-Cited by-同舟云学术

A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort

Published:2017-10-25 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Pedrini Steve, ,Gupta Veer B.,Hone Eugene,Doecke James^ORCID,O’Bryant Sid,James Ian,Bush Ashley I.^ORCID,Rowe Christopher C.,Villemagne Victor L.,Ames David,Masters Colin L.,Martins Ralph N.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-14020-9.pdf

Reference77 articles.

1. Price, J. L. & Morris, J. C. Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease. Annals of neurology 45, 358–368 (1999).

2. Krishnaswamy, S., Verdile, G., Groth, D., Kanyenda, L. & Martins, R. N. The structure and function of Alzheimer’s gamma secretase enzyme complex. Critical reviews in clinical laboratory sciences 46, 282–301, https://doi.org/10.3109/10408360903335821 (2009).

3. Zhang, H., Ma, Q., Zhang, Y. W. & Xu, H. Proteolytic processing of Alzheimer’s beta-amyloid precursor protein. Journal of neurochemistry 120(Suppl 1), 9–21, https://doi.org/10.1111/j.1471-4159.2011.07519.x (2012).

4. Arendt, T., Bigl, V., Arendt, A. & Tennstedt, A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer’s disease, paralysis agitans and Korsakoff’s Disease. Acta neuropathologica 61, 101–108 (1983).

5. Gomez-Isla, T. et al. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer’s disease. The Journal of neuroscience: the official journal of the Society for Neuroscience 16, 4491–4500 (1996).

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammation, Autoimmunity and Neurodegenerative Diseases, Therapeutics and Beyond;Current Neuropharmacology;2024-05

2. Evaluation of serum interleukin-12 and interleukin-4 as potential biomarkers for the diagnosis of major depressive disorder;Scientific Reports;2024-01-18

3. Evaluation of the Neuroprotective Effect of Organic Selenium Compounds: An in Vitro Model of Alzheimer’s Disease;Biological Trace Element Research;2023-10-07

4. Blood and CSF chemokines in Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis;Alzheimer's Research & Therapy;2023-06-08

5. Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment;Journal of Nanobiotechnology;2023-02-14